Abstract:Background Programmed necrosis/necroptosis is an emerging form of cell death that plays important roles in mammalian development and the immune system. The pro-necrotic kinases in the receptor interacting protein (RIP) family are crucial mediators of programmed necrosis. Recent advances in necrosis research have been greatly aided by the identification of chemical inhibitors that block programmed necrosis. Necrostatin-1 (Nec-1) and its derivatives were previously shown to target the pro-necrotic kinase RIP1/RIPK1. The protective effect conferred by Nec-1 and its derivatives in many experimental model systems was often attributed to the inhibition of RIP1 function. Methodology/Principal Findings We compared the effect of Nec-1 and siRNA-mediated silencing of RIP1 in the murine fibrosarcoma cell line L929. Treatment of L929 cells with the pan-caspase inhibitor zVAD-fmk or exogenous TNF induces necrosis. Strikingly, we found that siRNA-mediated silencing of RIP1 inhibited zVAD-fmk induced necrosis, but not TNF-induced necrosis. TNF-induced cell death in RIP1 knocked down L929 cells was inhibited by Nec-1, but not the caspase inhibitor zVAD-fmk. We found that PKA-C§ expression, but not Jnk or Erk activation, was moderately inhibited by Nec-1. Moreover, we found that Nec-1 inhibits proximal T cell receptor signaling independent of RIP1, leading to inhibition of T cell proliferation. Conclusions/Significance Our results reveal that besides RIP1, Nec-1 also targets other factors crucial for necrosis induction in L929 cells. In addition, high doses of Nec-1 inhibit other signal transduction pathways such as that for T cell receptor activation. These results highlight the importance to independently validate results obtained using Nec-1 with other approaches such as siRNA-mediated gene silencing. We propose that some of the previous published results obtained using Nec-1 should be re-evaluated in light of our findings.

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Structural Insights into RIP3-Mediated Necroptotic Signaling

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity.

RIP3-mediated necroptosis is regulated by inter-filament assembly of RIP homotypic interaction motif

RIPK3 signaling and its role in regulated cell death and diseases

Regulation of Ripk3-And Rhim-Dependent Necroptosis by the Proteasome

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Necrosome core machinery: MLKL

Distinct roles of RIP1–RIP3 hetero- and RIP3–RIP3 homo-interaction in mediating necroptosis

Targeting RIPK3 Oligomerization Blocks Necroptosis Without Inducing Apoptosis.

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

Uncovering Interactions of Mitochondrial Proteins BNIP3 and BNIP3L with Necroptosis-Associated Kinase RIPK3: Insights into Kinase Activation.

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke Via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

Biological events and molecular signaling following MLKL activation during necroptosis

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.